Llwytho...
Interleukin-22 acts as a mitochondrial protector
Interleukin (IL)-22 has been increasingly recognized as a promising therapeutic option for various types of diseases. This commentary summarizes the novel mechanistic aspects of IL-22 for the treatment of liver diseases including the study by Chen et al. published in the recent issue of the Theranos...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Theranostics |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Ivyspring International Publisher
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359092/ https://ncbi.nlm.nih.gov/pubmed/32685023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.48022 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|